This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Emergent BioSolutions Inc (EBS)

NYSE: Health Care

Company Balance Sheet
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Cash and Equivalents 179.34M 141.67M 143.90M 169.02M
Receivables 66.24M 96.04M 83.66M 48.05M
Inventories 14.64M 15.16M 14.66M 12.72M
Other Current Assets 0.00 0.00 0.00 0.00
Total Current Assets 273.12M 263.35M 254.42M 243.49M
Property, Plant & Equipment, Gross 321.61M 284.71M 241.43M 179.40M
Accumulated Depreciation & Depletion 57.37M 42.94M 32.46M 26.70M
Property, Plant & Equipment, Net 264.24M 241.76M 208.97M 152.70M
Intangibles 71.95M 0.00 51.40M 51.40M
Other Non-Current Assets 3.37M 42.53M 12.57M 13.94M
Total Non-Current Assets 353.52M 300.88M 292.45M 256.83M
Liabilities & Shareholder Equity
Total Assets 626.63M 564.23M 546.86M 500.32M
Accounts Payable 27.52M 31.30M 40.53M 25.41M
Short Term Debt 0.00 4.47M 5.36M 17.19M
Other Current Liabilities 1.34M 115.00K 1.75M 0.00
Total Current Liabilities 56.65M 61.91M 71.05M 75.72M
Long Term Debt 62.00M 58.30M 54.09M 30.24M
Deferred Income Taxes 1.42M 0.00 0.00 0.00
Other Non-Current Liabilities 17.40M 1.89M 4.99M 20.80M
Minority Interest -876.00K -5.38M -6.91M -4.51M
Total Non-Current Liabilities 80.36M 60.96M 61.56M 55.14M
Total Liabilities 137.01M 122.87M 132.62M 130.86M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 489.62M 441.36M 414.25M 369.46M
Common Par 37.00K 36.00K 36.00K 35.00K
Additional Paid In Capital 247.64M 230.96M 220.65M 197.69M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings 251.53M 220.39M 196.87M 173.85M
Treasury Stock -6.12M -5.91M 0.00 0.00
Other Equity Adjustments -3.46M -4.13M -3.31M -2.11M
Total Capitalization 551.62M 499.66M 468.34M 399.70M
Total Equity 489.62M 441.36M 414.25M 369.46M
Total Liabilities & Stock Equity 626.63M 564.23M 546.86M 500.32M
Total Common Shares Outstanding 36.62M 35.87M 36.00M 35.01M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 412.95K 403.16K 0.00 0.00
Basic Weighted Shares Outstanding 36.20M 36.08M 35.66M 31.78M
Diluted Weighted Shares Outstanding 36.75M 36.42M 36.21M 32.54M
Number of Employees 1353 877 811 767
Number of Part-Time Employees 0 0 0 0
EBS News

EBS Emergent BioSolutions Inc

Analysts Ratings for EBS

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 1 0 1 1
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0

Brokerage Partners

EBS Chatter

Select the service that is right for you!

Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs